Planning and Evaluation of Screening [EL022]

Course highlights

EC points


Start date


End date


Course days

Monday to Friday


Prof. Iris Lansdorp-Vogelaar, Dr. Esther Toes-Zoutendijk, Prof. Harry de Koning, PhD, and invited speakers

Course fee

€ 945


Erasmus MC, Rotterdam NL




  • Public Health


How to apply

Detailed information about this course:


This course focuses on the design and the evaluation of health care programmes for the early detection of disease or screening. Screening takes place in a population without symptoms of the disease. The screening test characteristics have consequences for the favourable (improvement of prognosis by early detection, life years saved and deaths prevented) and unfavourable (overdiagnosis, unnecessary treatments) effects of screening.

There are a number of designs for the assessment of the effectiveness of screening, such as randomized-controlled trials, observational prospective studies and case control studies. The pros and cons of each of these designs will be discussed. Evaluation methodologies, such as cost-effectiveness, cost-utility and technology assessment will be explained, including the concepts of quality adjustment of life years and of time preference. Detailed case studies include cervical, breast and prostate cancer screening, genetic screening, youth health care and screening for tuberculosis, e.g. for high risk groups. Several computer aids for the evaluation of screening are presented.

Only the afternoon sessions require physical presence.

See 'how to apply' for the course registration period.


At the end of this course, one should have obtained understanding of and insight in:

  1. determinants for effectiveness;
  2. measures for effectiveness of screening, levels of evidence for effectiveness, trial designs, implementation of trials;
  3. possible negative side effects, determinants of side effects;
  4. measurement of quality of life, quality adjustment of life years;
  5. the use of models for data analysis (describing the underlying natural history of the disease) and for predictions;
  6. definition of high risk groups;
  7. cost effectiveness analysis, optimization of strategies, time preference.

Participant profile

Both public health researchers and policy makers, with an interest in or opting to work in evaluation of health care facilities, in planning of such facilities targeted at populations (versus patient care level), in (secondary) prevention, in policy makin


Attendance, Assignment(s)

Reduction on fees

PLEASE NOTE: This does not apply to the fee of the research master programmes (120 EC points)

No fees are charged for  Erasmus MC PhD candidates, provided they have an account in Hora Finita, the Erasmus University PhD registration system. When submitting the application, you can state that someone else pays your tuition fee.

In case of cancellation or no show, the cancellation policy applies based on the full course fee.


25% reduction for all (international) PhD candidates without formal appointment at Erasmus MC

Upon receipt of your application you will receive a request to upload proof of enrollment as a PhD candidate.